Idexx Laboratories (IDXX)
$454.23 7.75 (1.74%)
16:35 EST IDXX Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 39.46B
PE Ratio 142.84
Volume (Avg. Vol.) 173,800
Day's Range 446.68 - 455.97
52-Week Range 168.65 - 485.00
Dividend & Yield N/A (N/A)
IDXX Stock Predictions, Articles, and Idexx Laboratories News
- From InvestorPlace
- From the Web
If you’re interested in high-growth biotech stocks with superior fundamentals, here are which ones to consider, and which ones to skip.
Global pet care sales could hit $203 billion by 2025. Here are seven pet care stocks to buy from the only pet care ETF in the U.S.
Tuesday's big stock charts look at 3 names that could reverse if market strength continues.
The stock market is off to its best year since 1997, and these tech stocks are leading that record rally. Here's what you should know.
Though most of the stocks in the Nasdaq ETF portfolio delivered strong returns so far this year, a few were the real stars, having gained more than 50%. Compare....
Here's a list of the top 20 performing stocks so far in 2018, how they got here and where they are going next.
The current recommendation of Buy for IDEXX Laboratories Inc (NASDAQ:IDXX) has been derived by using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing methodology. This represents no change from the previous week and is the same ranking IDXX has had from Portfolio Grader for 3 months.
While the MedTech industry has been grappling with multiple issues, these stocks with high growth potential can be great bets.
An Obamacare replacement is back in the news, and these seven A-rated healthcare stocks are winners regardless of how it shakes out.
These medical device stocks are primed to take advantage of the lifting of some rules and regulations out of Washington
With U.S. spending on our furry friends continuing to climb, Idexx Laboratories is well positioned for long-term growth and IDXX stock is worth a look.
From The Motley Fool
Navellier RatingsPowered by Portfolio Grader